Ledger.Open graph →
SEC Form D · Amendment · filed September 20, 2019

DTx Pharma, Inc

Offering
$12.5M
Sold
$12.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
SAN DIEGO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (6)

Sanket Wani · Malvern, PADirectorDaniel C. Davis · Campbell, CAExec · DirectorHigh Traverse Development, LLC · Salt Lake City, UTDirectorMichael J. Holmberg · Chicago, ILDirectorSam Konz · New York, NYExec · DirectorEric Felder · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗